Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate CancerNeal D. Shore, Bertrand Tombal, Hideyuki Akaza et al.|New England Journal of Medicine|2020Cited by 442
Use of intravesical valrubicin in clinical practice for treatment of nonmuscle-invasive bladder cancer, including carcinoma <i>in situ</i> of the bladderMichael S. Cookson, Ronald Tutrone, Sam S. Chang et al.|Therapeutic Advances in Urology|2014Cited by 50
Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO StudyRonald Tutrone, Neal D. Shore, Mark Fallick et al.|European Urology Oncology|2023Cited by 21